Rosa Leon Zazzarini
About Rosa Leon Zazzarini
Rosa Leon Zazzarini is an Associate Director at Bristol-Myers Squibb in New Brunswick, NJ, with extensive experience in regulatory affairs, particularly in CMC-regulatory affairs and Latin American markets.
Company
Rosa Leon Zazzarini currently holds the position of Associate Director at Bristol-Myers Squibb in the United States, specifically working out of New Brunswick, NJ. Bristol-Myers Squibb is a prominent global biopharmaceutical company known for its innovative medicines that help patients prevail over serious diseases.
Title
Rosa Leon Zazzarini serves as an Associate Director at Bristol-Myers Squibb. In her role, she likely oversees various projects and teams, contributing to the development and regulatory compliance of pharmaceutical products.
Education and Expertise
Rosa Leon Zazzarini has a strong academic background in chemistry. She earned a Master's degree in Analytical Chemistry from Stevens Institute of Technology, where she studied from 1983 to 1986. She also holds a Bachelor's degree in Chemistry from the Universidad Autónoma de Santo Domingo (UASD). Her expertise includes over a decade of experience in CMC-regulatory affairs, with a specific focus on Latin American markets, and more than 12 years in global regulatory affairs covering both development and marketing phases.
Background
Rosa Leon Zazzarini has a long-standing career in regulatory affairs across several pharmaceutical companies. Prior to her current role, she worked at sanofi-aventis as a Senior Regulatory Affairs Manager from 2006 to 2012 and at BMS from 2000 to 2006 as a Senior Manager. She has accumulated significant experience in managing regulatory affairs activities, with a particular focus on Chemistry, Manufacturing, and Control (CMC) regulatory affairs.
Achievements
Rosa Leon Zazzarini's career is marked by extensive experience and significant contributions to regulatory affairs in the pharmaceutical sector. With over a decade of specialized experience in CMC-regulatory affairs and more than 12 years in global regulatory roles, she has played a pivotal role in both the development and marketing phases of various pharmaceutical products. Her focus on Latin American markets further highlights her expertise in navigating complex regulatory environments.